Use of biomarkers of collagen types I and III fibrosis metabolism to detect cardiovascular and renal disease in chimpanzees (Pan troglodytes)

Comparative Medicine

Volumn 60, Issue 2, 2010, Pages 154-158

  Ely, John J ^a   Bishop, Micah A ^b   Lammey, Michael L ^a   Sleeper, Meg M ^c   Steiner, Jörg M ^b   Lee, D Rick ^a  

^a Alamogordo Primate Facility   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; INTERSTITIAL COLLAGENASE; PROCOLLAGEN; PROCOLLAGEN I N TERMINAL PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FIBROGENESIS; KIDNEY DISEASE; NONHUMAN; PAN TROGLODYTES;

ANIMALS; APE DISEASES; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COLLAGEN TYPE I; COLLAGEN TYPE III; FIBROSIS; HUMANS; KIDNEY DISEASES; MATRIX METALLOPROTEINASE 1; PAN TROGLODYTES; PEPTIDE FRAGMENTS; PROCOLLAGEN;

EID: 77951825280     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Adewale AJ, Liu Q, Dinu I, Lampe PD, Mitchell BL, Yasui Y. 2008. A cautionary note on the evaluation of biomarkers of subtypes of a single disease. Am J Epidemiol 168:559-562.
2. Barton PJ, Birks EJ, Felkin LE, Cullen ME, Koban MU, Yacoub MH. 2003. Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure. J Heart Lung Transplant 22:738-744.
3. Bland JM, Altman DG. 1996. Transformations, means, and confidence intervals. Br Med J 312:1079-1080.
4. Box G, Cox D. 1964. An analysis of transformations. J R Stat Soc Series B Stat Methodol 26:211-252.
5. Bozkaya YT, Aydin HH, Celik HA, Kayikcioglu M, Payzin S, Kultursay H, Aydin M, Yesil M, Can LH, Hasdemir C. 2008. Increased myocardial collagen turnover in patients with progressive cardiac conduction disease. Pacing Clin Electrophysiol 31:1284-1290.
6. Cononver WJ. 1980. Practical nonparametric statistics, 2nd ed. New York (NY): Wiley.
7. de Torres M, Poynard T. 2003. Risk factors for liver fibrosis progression in patients with chronic hepatitis C. Ann Hepatol 2:5-11.
8. Diez J. 2005. Serum markers of fibrillar collagen metabolism in cardiac diseases, p 101-113. In: Villarreal FJ, editor. Interstitial fibrosis in heart failure. New York (NY): Springer.
9. Doane CJ, Lee DR, Sleeper MM. 2006. Electrocardiogram abnormalities in captive chimpanzees (Pan troglodytes). Comp Med 56:512-518.
10. Duffy MS, Miller CL, Kinsella JM, de Lahunta A. 2004. Parastrongylus cantonensis in a nonhuman primate in Florida. Emerg Infect Dis 10:2207-2210.
11. Fassbach M, Schwartzkopff B. 2005. Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction. Z Kardiol 94:328-335. (Pubitemid 40684969)
12. Faul F, Erdfelder E, Lang A-G, Buchner A. 2007. G*Power 3: A flexible Statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175-191.
13. Gamble K. 2009. Personal communication.
14. Hansen JF, Alford PL, Keeling ME. 1984. Diffuse myocardial fibrosis and congestive heart failure in an adult male chimpanzee. Vet Pathol 21:529-531.
15. Harris EK, Boyd JC. 1995. Statistical basis of reference values in laboratory medicine. New York (NY): Marcel Dekker.
16. Higashikata T, Yamagishi M, Higashi T, Nagata I, Iihara K, Miyamoto S, Ishibashi-Ueda H, Nagaya N, Iwase T, Tomoike H, Sakamoto A. 2006. Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using a real-time RT-PCR method. Atherosclerosis 185:165-172. (Pubitemid 43117564)
17. Horiguchi T, Horiguchi T, Tachikawa S, Kondo R, Hirose M, Teruya S, Ishibashi A, Banno K. 2000. Usefulness of serum carboxy-terminal telopeptide (ICTP) of type I collagen as a marker of bone metastasis from lung cancer. Jpn J Clin Oncol 30:174-179. (Pubitemid 30335821)
18. Horn PS, Pesce AJ. 2005. Reference intervals. Washington (DC): AACC Press.
19. Hosmer DW, Lemeshow S. 2000. Applied logistic regression, 2nd ed. New York (NY): Wiley.
20. Hubbard GB, Lee DR, Eichberg J W. 1991. Diseases and pathology of chimpanzees at the Southwest Foundation for Biomedical Research. Am J Primatol 24:273-282.
21. Institute for Laboratory Animal Research. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
22. Jensen LT. 1997. The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology. Dan Med Bull 44:70-78.
23. Jordán A, Roldan V, Garcia M, Monmemeu J, de Burgos FG, Lip GY, Marin F. 2007. Matrix metalloproteinase 1 and its inhibitor, TIMP 1, in systolic heart failure: relation to functional data and prognosis. J Intern Med 262:385-392. (Pubitemid 47246973)
24. Jugdutt BI. 2005. Extracellular matrix and cardiac remodeling, p 23-55. In: Villarreal FJ, editor. Interstitial fibrosis in heart failure. New York (NY): Springer.
25. Kallergis EM, Manios EG, Kanoupakis EM, Mavrakis HE, Arfanakis DA, Maliaraki NE, Lathourakis CE, Chlouverakis GI, Vardas PE. 2008. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type I turnover. J Am Coll Cardiol 52:211-215.
26. Klappacher G, Frenzen P, Haab D, Mehrabi M, Binder M, Plesch K, Pacher R, Grimm M, Pribill I, Eichler H-G, Glogar HD. 1995. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol 75:913-918.
27. Kuhn C 3rd, Boldt J, King TE Jr, Crouch E, Vartio T, McDonald JA. 1989. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 140:1693-1703. (Pubitemid 20041056)
28. Lammey ML, Baskin GB, Gigliotti AP, Lee DR, Ely JJ, Sleeper MM. 2008. Interstitial myocardial fibrosis in a captive chimpanzee (Pan troglodytes) population. Comp Med 58:389-394.
29. Lammey ML, Lee DR, Ely JJ, Sleeper MM. 2008. Sudden cardiac death in 13 captive chimpanzees (Pan troglodytes). J Med Primatol 37 Suppl. 1:39-43.
30. Lin Y-H, Ho Y-L, Want T-D, Liu C-P, Kao H-L, Chao C-L, Chien K-L, Hung C-S, Wu V-C, Tsai I-J, Yen R-F, Shiau Y-C, Chen W-J. 2006. The relation of amino-terminal propeptide of type III procollagen and severity of coronary artery disease in patients without myocardial infarction of hibernation. Clin Biochem 39:861-866.
31. Lindsay MM, Maxwell P, Dunn FG. 2002. TIMP 1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 40:136-141. (Pubitemid 34840088)
32. Lombardi R, Betocchi S, Losi MA, Tocchetti CG, Aversa M, Miranda M, D'Alessandro G, Cacace A, Ciarnpi Q, Chiariello M. 2003. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 108:1455-1460.
33. López B, Gonzalez A, Querejeta R, Diez J. 2005. The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease. J Hypertens 23:1445-1451. (Pubitemid 41104811)
34. López B, Gonzalez A, Varo N, Laviades C, Querejeta R, Díez J. 2001. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 38:1222-1226. (Pubitemid 34252835)
35. Macías J, Berenguer J, Japon MA, Giron JA, Rivero A, López-Cortés LF, Moreno A, González-Serrano M, Iribarren JA, Ortega E, Mí ralles P, Mira J A, Pineda JA. 2009. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 50:1056-1063.
36. Marios R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, Patle A, Donnelly SC, McDonald K. 2007. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115:888-985. (Pubitemid 46294729)
37. McLenachan JM, Dargie HJ. 1990. Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. Am J Hypertens 3:735-740. (Pubitemid 20345997)
38. Melkko J, Niemi S, Risteli L, Risteli J. 1990. Raidoimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 36:1328-1332. (Pubitemid 120012240)
39. Moore R. Personal communication. 2008.
40. Muller KE, Benignus VA. 1992. Increasing scientific power with Statistical power. Neurotoxicol Teratol 14:211-219.
41. Munson L, Montali RJ. 1990. Pathology and disease of great apes at the National Zoological Park. Zoo Biol 9:99-105.
42. Namba T, Tsutsui H, Tagawa H, Takahashi M, Saito K, Kozai T, Usui M, Imanaka-Yoshida K, Imaizumi T, Takeshita A. 1997. Regulation of fibrillar collagen gene expression and protein accumulation in volume-overloaded cardiac hypertrophy. Circulation 95:2448-2454. (Pubitemid 27224741)
43. Pick R, Janicki JS, Weber KT. 1989. Myocardial fibosis in nonhuman primate with pressure overload hypertrophy. Am J Pathol 135:771-781. (Pubitemid 20009487)
44. Radovan J, Vaclav P, Petr W, Jan C, Michal A, Richard P, Martina P. 2006. Changes of collagen metabolism predict the left ventricular remodeling after myocardial infarction. Mol Cell Biochem 293:71-78. (Pubitemid 44843002)
45. Risteli J, Risteli R. 1990. Noninvasive methods for detection of organ fibrosis, p 61-98. In: Rojkind M, editor. Connective tissue in health and disease. Boca Raton (FL): CRC Press.
46. Salazar BL, Albéniz SR, Guedón TA, Miqueo AG, Querejeta R, Martinez JD. 2006. [Altered fibrillar collagen metabolism in hypeŕ tensive heart failure. Current understanding and future prospects]. Rev Esp Cardiol 59:1047-1057. [Article in Spanish]
47. Satta J, Juvonen T, Haukipuro K, Juvonen M, Kairaluoma MI. 1995. Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples. J Vase Surg 22:155-160.
48. Schaberg T, Orzechowski K, Oesterling C, Lode H, Schuppan D. 1994. Simultaneous measurement of collagen type VI-related antigen and procollagen type III N-propeptide levels in bronchoalveolar lavage. Eur Respir J 7:1221-1226. (Pubitemid 24235038)
49. Schulman FY, Farb A, Virmani R, Montali RJ. 1995. Fibrosing cardiomyopathy in captive western lowland gorillas (Gorilla gorilla gorilla) in the United States: a retrospective study. J Zoo Wildl Med 26:43-51.
50. Schwartzkopff B, Fassbach M, Pelzer B, Brehm M, Strauer BE. 2002. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy. Eur J Heart Fail 4:439-444. (Pubitemid 36564961)
51. Seiler BM, Dick EJ Jr, Guardado-Mendoza R, VandeBerg JL, Williams JT, Mubiru JN, Hubbard GB. 2009. Spontaneous heart disease in the adult chimpanzee (Pan troglodytes). J Med Primatol 38:51-58.
52. Sime PJ, O'Reilly KM. 2001. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol 99:308-319. (Pubitemid 32493696)
53. Sleeper MM, Doane CJ, Langner PH, Curtis S, Avila K, Lee DR. 2005. Successful treatment of idiopathic dilated cardiomyopathy in an adult chimpanzee (Pan troglodytes). Comp Med 55:80-84. (Pubitemid 41557549)
54. Snedecor GW, Cochran WG. 1967. Statistical methods, 6th ed. Ames (IA): Iowa State University Press.
55. Tanaka K, Zlochiver S, Vikstrom KL, Yamazaki M, Moreno J, Klos M, Zaitsev AV, Vaidyanathan R, Auerbach DS, Landas S, Guiraudon G, Jalif e J, Berenf eld O, Kalif a J. 2007. Spatial distribution of fibrosis governs fibrillation wave dynamics in the posterior left atrium during heart failure. Circ Res 101:839-847.
56. Tziakas DN, Chalikias GK, Papanas N, Stakos DA, Chatzikyriakou SV, Maltezos E. 2007. Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation. Europace 9:589-596. (Pubitemid 47263787)
57. Varki N, Anderson D, Herndon GG, Pham T, Gregg CJ, Cheriyan M, Murphy J, Strobert E, Fritz J, Else JG, Varki A. 2009. Heart disease is common in humans and chimpanzees but is caused by different pathological mechanisms. Evol Appl 2:101-112.
58. Wassmuth R, Schulz-Menger J. 2009. Cardiac magnetic resonance in acute myocarditis and dilated cardiomyopathy. Med Sci Monit 15:RA111-RA115.
59. Yamaoka A, Matsuo T, Shiraga F, Ohtsuki H. 2001. TIMP1 produc- tion by human scleral fibroblast decreases in response for cyclic mechanical stretching. Ophthalmic Res 33:98-101. (Pubitemid 32221229)